ClinicalTrials.Veeva

Menu

AQUACEL® Ag+ Extra™ and Cutimed™ Sorbact® Dressing in the Management of Venous Leg Ulcers Over a 12-week Period

Convatec logo

Convatec

Status

Completed

Conditions

Venous Leg Ulcer
Diabetic Foot

Treatments

Device: Cutimed® Sorbact®
Device: AQUACEL® Ag+ Extra™

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05892341
WC-22-435

Details and patient eligibility

About

Study is to provide evidence comparing AQUACEL® Ag+ Extra™ versus Cutimed® Sorbact® in the progression of wounds towards healing

Full description

Post market, multi-centre, randomised, open label, multi-national, prospective study to provide evidence comparing AQUACEL® Ag+ Extra™ versus Cutimed® Sorbact® in the progression of wounds towards healing

Enrollment

205 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Venous insufficiency as defined by CEAP Classification of C6
  • One wound amendable to treatment with either AQUACEL® Ag+ Extra™ or Cutimed® Sorbact®
  • Wounds that have been present for at least 2 months
  • Reliable and available for follow-up
  • 18 years or older
  • Able and willing to provide informed consent
  • Able to tolerate compression therapy for Venus Leg Ulcer
  • Must be able to be compliant with compression therapy

Exclusion criteria

  • Known sensitivities or allergies to components of the AQUACEL® Ag+ Extra™ or Cutimed® Sorbact®
  • Continued use of petroleum gel/ creams/ oil-based products
  • Active treatment for cancer or completed within the last 3 months
  • Documented severe malnutrition
  • Malignant wounds
  • Systemic infection actively treated with antibiotics

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

205 participants in 2 patient groups

AQUACEL® Ag+ Extra™
Active Comparator group
Description:
AQUACEL® Ag+ Extra™ is approved, needle-bonded nonwoven fabric layered and stitch-bonded wound dressing
Treatment:
Device: AQUACEL® Ag+ Extra™
Cutimed® Sorbact®
Active Comparator group
Description:
Cutimed® Sorbact® is approved, bacterial and fungi binding wound dressing
Treatment:
Device: Cutimed® Sorbact®

Trial contacts and locations

18

Loading...

Central trial contact

Markus Stuecker, MD; Catarina Saavedra, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems